Procurement intake management, explained.

One place to ask, and a route from the first sentence to a purchase order: procurement intake defined

A survey tool's five stages, from one sentence to forty seats

1. The employee asksIn plain words, in chat, by email or on a form, with a quote attached if there is one. In the example, a patient advocacy manager asks for a survey tool on October 7.
2. The request is read and routedIs it a purchase at all? Is it in the catalog? Does a contract or license cover it? Only then a new supplier. This step is what this guide is about.
3. The policy steps runQuotes, a security review, a privacy review, supplier due diligence, a statement of work, whichever the route and the value call for.
4. People approve, in orderThe delegation of authority sets the chain from the value, apart from any small orders the policy approves automatically. Nobody approves their own request.
5. The order goes out, and the record staysA person posts the requisition to the finance system, the PO issues, and the requester can see where it went. In the example no PO is needed: seats are assigned the next day.

This example's people, companies and figures are fictional.

Four surprises in life sciences buying: idle seats, doctors' fees, slow reviews and shrinking teams

Buying vocabulary to learn first: requisition, delegation of authority, call-off, statement of work

Thirteen terms are defined in the one-page summary.

Five ways to buy at a life sciences company, and the requests that are not purchases

In shortMost buying policies name a fixed order: the catalog, then an existing contract or license, and only then a new supplier, a sourcing event or a new statement of work. Each route triggers its own checks and its own clock. An employee cannot be expected to know which applies. Sorting the request correctly in the first hour decides whether it takes minutes or weeks.

The order matters because each step down costs more. A catalog item has a negotiated price and needs almost no judgment. An existing contract was already competed and already passed legal review, so an order under it borrows that work. A new supplier means sanctions screening, a questionnaire, bank verification, perhaps a financial review, and often a security assessment. The exact routes differ by company, but their logic rarely does.

HCP means healthcare professional. A category manager is the buyer who owns one kind of spend, such as research services. The table is our summary of common practice; your policy sets your routes.

Why "do we already own it?" comes before any quote or review

A review that runs in the wrong order wastes everyone's week. If security assesses a tool before anyone checks the license register, the assessment may be for a purchase nobody needs. If a buyer collects three quotes before anyone notices the request is a fee to a doctor, the quotes are wasted and the request is in the wrong process.

So the first question is always whether it is a purchase at all, and the second is whether you already own it. Only then do thresholds and reviews matter. Getting this order right costs nothing and removes whole steps.

Lab services, coded samples and doctors' fees: what makes buying harder at a drug company

In shortThree things separate life sciences buying from a general office budget. Much of the spend is research services, priced on rate cards (schedules of agreed prices) and hard to compare. Some suppliers touch regulated work, so the buyer stays responsible for them. And some requests carry patient data or involve doctors. A request form cannot see any of that; someone has to ask the right question at the start.

Suppliers whose work ends up in a regulated record

A drug manufacturer stays answerable for what it buys. Under US good manufacturing practice (GMP), a supplier's report of analysis can stand in for most testing of a component only if the manufacturer runs at least one specific identity test and "establishes the reliability of the supplier's analyses" through validation at intervals.7 The quality unit also answers for products made under contract by another company.8

ICH Q10, the global guideline on pharmaceutical quality systems, puts it in one line: the company "is ultimately responsible" for having processes that assure the control of outsourced activities and the quality of purchased materials.9 The EU GMP guide adds that before outsourcing, the company is responsible for assessing "the legality, suitability and the competence" of the other party.10 FDA's 2016 guidance on quality agreements says the same of contract manufacturing: the owner remains responsible for its products, whoever makes or tests them.11

Clinical trials work the same way. ICH E6(R3), the global guideline on good clinical practice, in effect in the EU since July 23, 2025, says the sponsor, the company running the trial, is responsible for "assessing the suitability of and selecting the service provider", and that agreements should be documented before activities begin.12

Device makers have their own version: FDA's Quality Management System Regulation, effective February 2, 2026, removed Subparts C through O of the old Part 820, and with them the purchasing controls at 21 CFR 820.50. It brings in ISO 13485, the international standard for device quality systems, whose clause 7.4 has a company evaluate suppliers in proportion to the effect and risk of what they supply.13

What this means for intake: "just use this lab" is rarely a simple request. A lab already qualified under a master agreement carries different risk from one a scientist found at a conference, even at a lower price. That is one reason buying policies push requests toward what has already been checked.

Requests that carry patient data, and how little it takes

A survey tool that holds names and emails of a patient panel is software holding personal data. A blood sample labeled with a code in place of the patient's name can carry personal data too. Four points of EU law shape the review such a request needs, and the answer can depend on who holds the data, so ask your privacy team.

Payments to doctors that must not travel as purchases

Under the US Open Payments program, an applicable manufacturer, broadly a maker of a covered drug, device, biological or medical supply, reports payments and other transfers of value to covered recipients, such as doctors and teaching hospitals, to the Centers for Medicare & Medicaid Services (CMS) each year.4 Penalties are civil and set per item, at 2025 levels that the Department of Health and Human Services (HHS) left unchanged for 2026.18

Speaker programs carry their own warning: the HHS Office of Inspector General issued a Special Fraud Alert on them in November 2020.20

Judging those payments belongs to compliance. Procurement's job is to spot the request early and hand it over, with the details filled in so the employee does not start again.

The rules one purchase request can trip in November 2026: GxP, BIOSECURE, DOJ's data rule, Open Payments and SOX

In shortNo law governs procurement intake as such. Each request may fall under rules owned by other teams: quality (GxP, the good-practice rules for manufacturing, labs and trials), privacy, compliance, finance and national security. Two of them are new. BIOSECURE, which limits federal money going to certain biotechnology companies, became law in December 2025, with its limits still to start. DOJ's data rule took full effect in October 2025. Intake is where those rules first meet a purchase, so it is the cheapest place to ask the question.

BIOSECURE reaches federal contractors and grantees, and a private purchase can touch it

BIOSECURE is law: section 851 of Public Law 119-60, approved December 18, 2025. Once its limits apply, an executive agency may not buy biotechnology equipment or services from a biotechnology company of concern. Nor may it contract with an entity that uses such equipment or services in performing the federal contract, if acquired after the effective date. Loan and grant recipients face matching limits.22

The limits have not started, and they wait on the steps in the chart below. We found no published list or FAR revision on November 3, 2026. So a company with federal contracts or grants needs to know which of its purchases could feed that work. The section does not ban private buying as such. Intake is a sensible place to flag the supplier and the program, and legal decides.

DOJ's data rule treats some vendor agreements as restricted transactions

The rule, on access to sensitive US personal data by countries of concern, is 28 CFR Part 202. It took effect April 8, 2025, with due diligence and audit parts following on October 6, 2025.21

Its "vendor agreement" covers any agreement "in which any person provides goods or services to another person" for payment. If that vendor is a covered person, broadly a company or individual tied to a country of concern by ownership, base, employment or residence, or sits in a country of concern, and the data passes a bulk threshold, the transaction may be restricted or prohibited. The thresholds are low for this industry.

Sections 202.510 and 202.511 hold exemptions, on conditions, for certain regulatory approval data and FDA-regulated clinical investigations; the rule's own examples show they do not cover every vendor arrangement.21 Ask counsel. A request for a lab or data host should prompt the question early.

Which team owns each rule, and the one question intake should ask

Detailed checks live with each owner: intake only needs the question that routes the request to them. Vendor security reviews and anti-bribery reviews of distributors go much deeper than intake does, and they belong to their own teams.

Who is an employee and who is a contractor: the test keeps moving

A request for "writing help" can hide a staffing question. If a person works under your direction, on your premises, for an open-ended time, labor law may treat them as your worker whatever the statement of work says.

In the US, the Department of Labor proposed on February 27, 2026 to rescind the analysis in its 2024 independent contractor rule and replace it with its 2021 analysis, with a few changes, which treats control and opportunity for profit or loss as the two core factors. Comments closed April 28, 2026, and we found no final rule on November 3, 2026, so this is still a proposal.

Since May 1, 2025 the department's own investigators have not applied the 2024 analysis, and its bulletin says the 2024 rule stays in effect for private lawsuits until further action.25

National tests differ and change, so most policies send these requests to a contingent worker process run with human resources. Intake's part is one plain question: will this person deliver something finished, or work day to day inside your team?

The five records that decide a route, and why each one is usually out of date somewhere

In shortA correct route rests on a policy, a delegation of authority, a contract set, a license register and a supplier master, plus whatever the employee attached. They sit in different systems with different owners. A person who knows all five is rare and overloaded. Clean, dated records do more for routing than any clever software, so check them first.

Why one contract search can take a morning

Take a scientist who needs a ligand-binding assay validated: a test that measures a drug or marker in blood, validated under ICH M10, the global guideline on bioanalytical methods.26

A buyer must first translate that into the words used on a rate card. Then they must find which master agreements cover bioanalysis, open the schedules, confirm the analyte count (how many substances the test measures), check the contract is in term, check whether it was competitively sourced, check whether the data schedule allows coded samples, and see whether this supplier has run this assay before.

None of those steps is hard. Each one lives in a different document, and the buyer has twenty other requests open.

World Commerce & Contracting, a trade association, put the broader cost of weak contracting at 9.2% of contract value in 2014. Its update with Deloitte, on more than 1,200 organizations, put it at 8.6%, as reported in August 2023.27 Those figures cover far more than intake, and they are its own estimates. They still show why buyers bring agreements into the conversation from the first sentence.

How thresholds, split purchases and approval chains are worked out, with the arithmetic

In shortThree calculations sit under every route: which value band a request falls in, whether requests must be added together, and who signs at that value. Each one is simple alone. The errors come from using the wrong value: the first year instead of the contract's lifetime, one invoice instead of the whole series, or the supplier's quote instead of the rate-card price.

Value bands: a sample policy's three quote rules

The figures in this section come from the guide's fictional buying policy, a realistic shape that your own will vary from.

If a purchase above $100,000 is not competed, the requester files a sole-source justification, a written reason for buying without competition, and a category manager approves it.

Adding up a split purchase: two $54,000 requests make one $108,000 purchase

A team plans a patient video series of eight films and splits the budget across two quarters. Part 1 goes in on October 2 for $54,000. Part 2 goes in on October 7, also for $54,000, to the same supplier from the same cost center. Each sits comfortably under $100,000. Together they come to $108,000, and the policy adds requests to the same supplier within 30 days from the same cost center. So the purchase needs a sourcing event.

Splitting is often innocent: budgets come in quarters, and nobody meant to dodge anything. A control has to catch it either way, and asking one question separates the cases: is part 2 a separate project, or the same series?

Reading a delegation of authority: why $164,800 needs three names

The sample table gives a cost-center manager authority up to $25,000, a director from $25,001 to $150,000, a vice president from $150,001 to $500,000, a senior vice president to $2,000,000 and the CFO above that. Above $100,000, procurement signs as well. And nobody approves a request they raised, or a request for a supplier they manage. So a $164,800 assay validation runs to a budget owner, then a vice president, then a procurement sign-off. At $96,000 it would stop with a director.

Comparing two prices fairly: rate card against a new supplier's quote

Price is rarely the only sum. In the guide's example, the scientist's preferred lab quotes $182,400 and could start around November 24, after 15 to 25 working days of set-up. The agreement's rate card says $164,800 and a start of October 27. The difference is $17,600 and about four weeks.

Whether four weeks matter depends on the program. In published work from the Tufts Center for the Study of Drug Development, one day of delay in Phase II or III costs about $40,000 in direct trial cost. The same dataset gives about $500,000 in lost sales in the journal article and about $800,000 in its white paper.28,29 Those are averages across trials, and a lab validation does not always sit on a critical path, so ask whether yours does.

Idle licenses and off-contract buying: what vendors' own benchmarks claim, and how to test them

In shortAlmost every published number here comes from a company selling a fix, so read each one as a claim with its date on it. They agree in direction: many licenses sit unused, a large share of spend runs outside contracts, and approvals take long. No independent life sciences figure was found. Your own register and spend file can answer the question in a week.

Zylo says the waste comes to about $19.8 million a year at the average organization in its data.3 Its method is not on the page we read, and its customers are companies already worried about software costs.

A seat that looks idle may also be held for a reason: a pending hire, a seasonal study, or a license tier that does not fit the new need. So a free seat is a reason to ask, and fit still has to be checked. For patient data, that means asking whether the tool was cleared for that kind of data, which is why the check belongs next to the license record.

On off-contract buying, Zycus, another seller, cites Ardent Partners' 2025 report for the figure that "only 62.2% of enterprise spend is contract compliant".30 We could not read Ardent's report itself, so treat it as a figure passed along by an interested party. Zycus's post also says each maverick dollar, meaning money spent outside agreed contracts or channels, costs "12% to 18% more", naming no source. We leave that one out, and you should ask anyone who quotes it where it came from.

Testing the vendors' claims on your own spend in a week

Work before a PO, a split requirement, a near-name supplier: the seven common failures in a purchase request

In shortMost failures start with a request nobody read properly: work already begun, a requirement split in two, a near-name supplier taken for an approved one, a doctor's fee sent as an invoice. Few are fraud, and each is cheap to catch at the start and expensive after the fact. Published fraud data shows why the controls exist, and a European case shows what an unreliable contractor can cost.

No public figure was found for how often the first seven happen at drug or device companies. Section 07 shows how to count your own.

Tips matter as well. The Association of Certified Fraud Examiners found that 43% of the frauds in its study came to light through a tip, and that almost one third of tips came from vendors and customers.31 A supplier who sees something odd needs a route to say so, and that route starts with knowing who owns the relationship.

When a contractor's records fail: more than 400 medicines reviewed, and suspensions across the EU

In 2023 and 2024 the European Medicines Agency reviewed generic medicines tested by one contract research organization, Synapse Labs, after a good clinical practice inspection found "irregularities in study data and inadequacies in study documentation", along with problems in its computer systems and data procedures. The Commission's binding decision came on May 24, 2024, and suspensions followed for medicines without other supporting data. EMA said there was "no evidence of harm or lack of effectiveness" with the affected medicines.33

This case is about one regulator's finding on one firm, and no purchase route would have revealed it. It does show what sits behind the rule that a sponsor stays responsible: the companies whose products relied on that testing bore the consequence.

Who sells intake-to-procure software, what analysts say, and what the adoption figures leave out

In shortIntake became its own software category over the past few years, and procurement suites and independent specialists both sell it. Analysts place it on a path to the mainstream. Adoption of AI in procurement is rising quickly from a low base, and large-scale use remains rare. The strongest results are vendor stories about unnamed customers, so treat them as things to test on your own requests.

Gartner placed intake management on its Hype Cycle for Procurement and Sourcing Solutions in 2023, with mainstream adoption predicted "to mature within 2-5 years", in the words of a vendor named in that report, writing in August 2023.34 We did not read Gartner's report. Sellers include specialist intake firms, large source-to-pay suites that added it, and workflow tools. Compare all three if you can: they differ most in how much they read for themselves and in how they connect to your finance system.

Analysts are cautious about the speed. Gartner said in July 2025 that generative AI for procurement had entered "the trough of disillusionment" and projected it would become fully productive within five years, as DCAT Value Chain Insights reports.35 A Gartner survey of 101 chief procurement officers in January and February 2026 found only 36% very confident in their ability to redesign roles and processes for AI. We read a trade summary of that release, dated May 19, 2026.36

How to read a vendor's number on intake

AI reads and matches purchase requests well: what regulators have said, and where people stay in charge

In shortAI reads free text, finds the matching agreement and drafts the next form well. It can also misread a clause, and a supplier's quote may carry hidden instructions. Most regulators' AI texts do not aim at this kind of internal work, but quality, privacy and finance rules still apply to its results. Keep people on exceptions, approvals and posting, and show the source for every step.

Seven AI and records texts an intake tool may meet, with their status in November 2026

Hidden instructions, chatbot promises and near names: three risks when software reads a request

From shared mailbox to purchase order: who handles a request by hand, and where about six working days go

In shortA typical request passes through a requester, a buyer, one or two reviewers and a chain of approvers, mostly by email. An estimated six working days go by before a PO on a request covered by an existing contract, and much of that is finding out, asking and re-keying. Approvals take time as well, though they often take the blame for time spent elsewhere.

The six roles a purchase request passes through, from requester to accounts payable

Five ways to run intake, from a shared mailbox to software that reads

Sam's one-sentence request for a survey tool meets 312 free seats, and the route changes

In shortThe survey tool from the top of the page, now on screen, on October 7. Sam Patel, a patient advocacy manager, types what he needs and names a tool he likes. The conversation asks two questions while the route builds beside it. The company's license has free seats cleared for panel data, so the tool he named is held back with its clause. He gets 40 seats the next day, and he can still ask for his choice as an exception.

1

A place to ask, with no form to choose

Sam opens New request. There is one line: what do you need? Beside it, the route waits to be built, in the order the buying policy sets: is it a purchase, the catalog, contracts and licenses, and only then a new supplier or quotes. A thin line of sample figures sits above, and the company's records wait behind: 4,310 catalog items, 212 agreements, 38 licenses with 1,904 seats unassigned.

He writes: "We need a survey tool for our patient advisory panel, about 40 seats, roughly $18,000 a year. We liked Pollen Survey."

2

Seats found before anything new, and the named tool held back

The request classifier reads a software subscription in the $10,000 to $100,000 band. The catalog has no survey software. The Thornquill Research Cloud license has 312 unassigned seats, which fits if it may hold the panel's data, so the conversation asks exactly that. Pollen Survey shows as held back, with clause 7.5 beside it: unused seats come before a new tool.

Each row names the agent behind it, and the clause chip opens the passage.

3

Two answers, and the route is set with its reasons

Sam taps two answers: yes, names and emails; by November 1. Thornquill passed IT security assessment SA-2291 for panel members' personal data, so the route is the company's license: seats ready tomorrow, no cost to his budget, no PO needed. Three agents confirm it in 2.0 seconds on this sample. Each numbered reason opens the record behind it.

A note keeps the choice open. Pollen Survey as a new supplier needs a security assessment, a privacy review and three quotes, typically four to six weeks, and one link sends it to a person as an exception.

4

Who signs, and what Sam sees next

With no spend, there is nothing for a director to approve. The Thornquill administrator assigns the seats, and Laura Kessing, Sam's director, is informed. Sam sends it, and request REQ-24131 opens with a tracker: asked, route chosen, seat request sent, 40 seats assigned, welcome email to his team.

In the Requests list this one reads Existing license, $0 and seats, at the stage called Release drafted, the sample's word for the seat request.

A scientist names a lab, an agreement already covers the assay, and the $164,800 route waits for a person

In shortA scientist, Dr. Maya Chen, attaches a $182,400 quote from a lab that is not a supplier. An agreement covers the same assay at $164,800, and that lab ran it last year. The agents are 88% sure, and she named someone else, so the route waits for Priya Ranvelle, the procurement operations lead. She compares two options side by side and confirms one. The work order and the note to Maya are drafted, and a person posts the requisition.

1

The request and the checks behind it

Maya asked at 8:12 am for a lab to validate the sTRX-7 ligand-binding assay on VLT-302 serum samples, attaching a quote from Kelbrook Bioanalytics. The intake guide read the quote, three analytes and 12 weeks, and asked two things: will coded patient samples leave Northwind, and which cost center pays?

Priya's screen lays out the routing decision as a list of tests, each with the passage behind it. Marrowbrook Lab Services covers it under master agreement MSA-0418, rate card item BA-14. The agreement was competitively sourced under request for proposal RFP-2025-031, and its Schedule 4 covers the coded samples. Kelbrook is not in the supplier master. A different firm, Kelbrook Lab Supplies GmbH, is, with another registration number and bank account, and the agents do not treat them as one company.

2

Two routes, side by side

The Marrowbrook agreement starts October 27 at $164,800, as a statement of work under MSA-0418, about 2 days to a PO. Adding Kelbrook as a new supplier would start about November 24 at $182,400, after due diligence and a sole-source justification, 15 to 25 working days to a PO. Each option cites its clause. Priya can also send the question back to Maya.

The approval chain is already built from the value: Dr. Henrik Aldersen, the director and budget owner; Grace Whitfield, the vice president, in the $150,001 to $500,000 band; and Omar Haddad for procurement's sign-off above $100,000.

3

The work order and the note, drafted

Priya confirms. Work order SOW-0418-031 is drafted from rate card BA-14: method transfer in week 2, validation runs in weeks 3 to 9, a validation report in week 12 that meets ICH M10 criteria, $164,800 fixed. Maya's note says the lab starts a week before her date, at $17,600 below the Kelbrook quote, and it explains why.

Drafts stay drafts. A person posts the requisition, and the agent that pre-fills forms cannot change agreed prices. The tracker nudges the next approver once a working day, with the request and its reasons attached.

A split video series, an invoice with no PO, a writer who may be staff, and fees that leave procurement

In shortFour more sample requests show why a form is not enough. Two parts of a video series add up to a sourcing event. A translation invoice arrives with no PO and must be ratified. A writing request could be a deliverable or a person working under direction. And fees to doctors go to a different process with the details filled in. Pipette tips, meanwhile, fall under the sample policy's one automatic approval: catalog orders under $1,000, within budget.

$54,000 and $54,000: the split purchase the 30-day window catches

Sam asks for part 2 of a patient video series from Hollin Story Films, five days after part 1. The agent asks whether it is a separate project, and Sam says it is the same series, split across two budget quarters. The two together reach $108,000, above the $100,000 line. The recommendation is one sourcing event, and Priya can keep two requests only with a justification on record. Nobody is accused of anything: the screen states the arithmetic and the clause.

$9,800 with no purchase order: ratifying work already done

Wordmere Language Partners sent an invoice for 14 patient materials translated into six languages, delivered September 22, with no PO reference. Tom Halwick, in Medical Affairs, explains that a leaflet update had a 10-day deadline from the agency. The route is a ratification after the fact by Priya and the cost-center owner, with the reason recorded and the case listed in the October exceptions review. The supplier did the work it was asked to do. The gap was on Northwind's side.

Deliverable or day-to-day: a 61% call that goes to a person

Dr. Aisha Rahman, in Regulatory Affairs, needs writing help to finish the Module 2.7 clinical summaries of a drug application, about $96,000. Asked whether the writer delivers finished summaries or works inside her team, she says mostly finished summaries, with daily stand-ups and use of the document system. The agents are 61% sure, well under the 90% line for confirming a route on their own, so the question goes to Priya.

One option is a deliverable-based statement of work under Halvorsen Regulatory Consulting's MSA-0377. The other sends it to human resources as a contingent worker. Clause 6.4 is on the screen for both, and the deliverables are defined in the draft.

Advisory board fees and pipette tips: the two ends of the buying order

Sam also needs to pay 8 dermatologists at an advisory board in November, about $19,200. One question, are they paid healthcare professionals, takes it out of procurement under clause 8.1. The engagement request is filled in with his details, so he does not start again, and compliance drafts the contracts, with fees set at fair market value. Compliance also decides what kind of engagement this is: the sample's wording mixes speaker fees and an advisory board, and those are handled differently.

Maya's 20 racks of filter pipette tips go the other way. The LabNorth catalog has item 77-2041 at $4.68 a rack, $93.60 in all, and the sample delegation of authority approves catalog orders under $1,000 automatically, within the cost-center budget. PO 4500311902 issues in six minutes on the sample. People wrote that rule into the policy, and every other purchase on these screens waits for a named approver.

The route board, the policy library and the dashboard: every open request and the clause behind it

In shortProcurement sees every open request as a stop on a line, with late ones marked and exceptions waiting below. The Requests list filters by route and status. The policy library shows what the agents read, highlighted where each request cites it. The dashboard counts requests, days, route mix and clauses. Dashboard figures are design targets on sample data, and they are measured live once the solution runs on your requests.

Who does what on a purchase request: six agents that draft, people who sign, and targets to test

In shortSix agents ask, classify, match, route, draft and track, each with something it must never do. A route confirms itself only above the confidence line, and only when no exception applies. Everything else waits for a person. Named people approve the spend under the delegation of authority, apart from the small catalog orders the policy approves automatically. The solution works with the channels and records you already have. Outcome figures are design targets, measured when the solution runs on your requests.

Intake guide to request tracker: what each agent does and must never do

The solution's page calls the matcher the Contract & license matcher. It is the same agent as on these screens.

Who signs what on a purchase request: exceptions, values and reviews

The four-eyes rule, that no one checks their own work, runs through it: the person who raises a request cannot approve it, and a person who manages a supplier cannot approve a purchase from that supplier. If a cost-center manager raises a request, it routes up a level.

Every agent step, decision, nudge and setting change lands on the activity trail with who and when. The product's own security credentials are a SOC 2 Type II audit and information security managed to ISO 27001. For your GxP and financial duties, the solution provides controls that support your compliance, and the responsibility stays with you.

From one sentence to a posted requisition: the records read and the drafts produced

Chat, contract repository, license register, ERP: where a purchase request plugs in

1.9 days to a PO and 58% kept on what you own: design targets to test on your requests

The price of idle seats, unneeded suppliers and a slow route at a drug or device company

In shortNo independent life sciences benchmark was found for most of this. Published figures describe contracts, trial delay and fraud in general. Your real costs sit in license renewals, new-supplier set-ups, buyer hours and work that started late. A week with your finance export, your license register and your last 100 requests gives you a number you can defend.

Where procurement leakage hides, and how to find your number in a week

Costs a return calculator leaves out: a delayed study, a bad bank change, an unreviewed tool

Buyer hours, avoided suppliers and reused seats: the return on routing purchase requests

In shortThe return comes from buyer hours, new suppliers you avoid and seats you reuse. A fourth lever, time to a PO, matters and carries no dollar figure here. Defaults below are illustrative. The seat price comes from the guide's fictional example. Replace every input with your own before you show this to anyone.

Three formulas for the return, and the lever left out of the sum

What 6,000 purchase requests a year could return, or your own count

Formulas: buyer time = requests × (hours today − hours after) × hourly cost; set-ups = suppliers avoided × set-up cost; seats = seats reused × price per seat. Every default is an assumption for you to replace, and we found no published source for them. Freed hours turn into money only if the team spends them elsewhere or grows more slowly, so state which. The total leaves out software and running costs.

Scoring your buying policy, agreements and license register for automated routing

In shortPick the answer closest to your team today. Eight questions score 0 to 2, and the last one is for reflection. Routing software reads your records, so most of these questions ask how good those records are. A low score points to useful work you can start now, and that work pays back with or without software.

What a procurement team does at each score

Twelve questions for intake-to-procure vendors on routes, clauses, unused seats and your data

In shortAsk for a demonstration on your own policy and your own requests. Software that reads well on its own sample tells you little. Ask us too. These questions are written so a strong answer shows on the screen, and a weak one sounds like a roadmap.

Replay 300 of last quarter's purchase requests, then take one category live: an eight-week pilot

In shortReplay real requests first, because you already know how they turned out. Compare the routes with your team's choices and argue about each difference. Then run one category live, such as research services, with a person on every exception. By week eight you will have your own numbers for days, routes and buyer hours.

Route match, citations and days to a PO: scoring the replay and the live category

What buyers search about procurement intake: intake-to-procure, no PO no pay, split purchases and AI approvals

In shortWhat people type into a search box on this subject, each answer written to stand alone. Vendor figures carry the vendor's name and date. Rules are stated as of November 2026.